Linker Information
General Information of This Linker
| Linker ID |
LIN0HCDIC
|
|||||
|---|---|---|---|---|---|---|
| Linker Name |
DVP-based linker 3
|
|||||
| Linker Type |
Flexible dual-reactive (amino/thiol) linker
|
|||||
| Antibody-Linker Relation |
Cleavable
|
|||||
Each Antibody-drug Conjugate Related to This Linker
Full Information of The Activity Data of The ADC(s) Related to This Linker
Trastuzumab-DVP-linker-MMAE 3 [Investigative]
Revealed Based on the Cell Line Data
| Experiment 1 Reporting the Activity Date of This ADC | [1] | ||||
| Efficacy Data | Half Maximal Inhibitory Concentration (IC50) |
2.40 nM
|
Positive HER2 expression (HER2+++/++) | ||
| Method Description |
Cells were seeded at 2000 cells per well in black 96-well proliferation plates and dosed with a titration of conjugates for 3 to 5 days, until control untreated cells reached 80 to 90% confluence.
|
||||
| In Vitro Model | Invasive breast carcinoma | BT-474 cells | CVCL_0179 | ||
References
If you find any error in data or bug in web service, please kindly report it to Dr. Shen et al.